Route, Frequency and Other Abbreviations: IP = intraperitoneal IM = intramuscular IV = intravenous SQ = subcutaneous PO = “per os” (by mouth) BW = body weight SID = once a day (as close to every 24 hrs as possible) BID = twice a day (as close to every 12 hrs as possible) TID = three times a day (as close to every 8 hrs as possible) QID = four times a day (as close to every 6 hrs as possible) q X h(rs) = every X hours
ANESTHETICS COMMENTS Of 1.25% solution1
0.2 ml/10 g BW
30 min duration; 60 – 90 min sleep time
Recommended for minor survival procedures
30 min duration; 40 – 120 min sleep time
Partially reversible with Yobine® (yohimbine)
Recommended for minor survival procedures
30 min duration; 60 – 120 min sleep time
Partially reversible with Yobine® (yohimbine)
Recommended for minor survival procedures
20 – 30 min duration; 60 – 120 min sleep time
20 – 30 min duration; 60 – 120 min sleep time
Reversible with Antesedan® (atipamezole) or Yobine®
30 – 40 min duration; 60 – 120 min sleep time
Reversible with Antesedan® (atipamezole) or Yobine®
Recommended for minor survival procedures
20 – 40 min duration; 120 – 180 min sleep time
Followed by 25 mg/kg SQ for longer procedures (45-50 min)
MOUSE REVERSAL AGENTS
1 No longer available commercially but can be made. For concentrated solution, (66 2/3 %), dissolve 1 g 2,2,2-tribromoethanol in 0.5 g amylene hydrate. Take 0.5 ml concentrate and mix with 39.5 ml sterile saline. This is now a
1.25% solution. If solution falls below pH 5.0, discard. Stored solutions are known to be unstable and potentially hepatotoxic. Frequent use may induce chemical peritonitis. Protect from light and store under refrigeration. 2 Ketamine used alone in mammals is not usually adequate for deep anesthesia. 3 C-III controlled drug 4 C-IV controlled drug 5 C-II controlled drug 6 Survival procedures require the use of a precision vaporizer for isoflurane gas delivery. Bell jars may be used for ultra-short non-survival procedures. The animals may not come into contact with the isoflurane and the use of a chemical fume hood is required. Isoflurane will fog and melt plastics.
ANALGESICS (PAIN RELIEVERS) FREQUENCY COMMENTS May cause respiratory depression
No known efficacy or toxicity studies in
1 NSAID 2 Opioid 3 C-III controlled drug
SEDATIVES COMMENTS
Partially reversible with Yobine® (yohimbine)
Good immobilization, poor muscle relaxation
Reversible with Antesedan® (atipamezole) or Yobine®
MOUSE REVERSAL AGENTS
1 Ketamine used alone in mammals is not usually adequate for deep anesthesia. 2 C-III controlled drug 3 C-IV controlled drug
ANESTHETICS COMMENTS 10% solution; Minor survival surgery only
Partially reversible with Yobine® (yohimbine)
Partially reversible with Yobine® (yohimbine)
Partially reversible with Yobine® (yohimbine)
Reversible with Antesedan® (atipamezole) or Yobine®
Reversible with Antesedan® (atipamezole) or Yobine®
Major survival surgery Major survival surgery
RAT REVERSAL AGENTS
1 Ketamine used alone in mammals is not usually adequate for deep anesthesia. 2 C-III controlled drug 3 C-IV controlled drug 4 C-II controlled drug 5 Survival procedures require the use of a precision vaporizer for isoflurane gas delivery. Bell jars may be used for ultra-short non-survival procedures. The animals may not come into contact with the isoflurane and the use of a chemical fume hood is required.
ANALGESICS (PAIN RELIEVERS) FREQUENCY COMMENTS May cause respiratory depression;
1 NSAID 2 Opioid 3 C-III controlled drug
SEDATIVES COMMENTS
Deep sedation, immobilization, mild to moderate analgesia
Partially reversible with Yobine® (yohimbine)
Reversible with Antisedan® (atipamezole) or Yobine®
RAT REVERSAL AGENTS
1 Ketamine used alone in mammals is not usually adequate for deep anesthesia. 2 C-IV controlled drug 3 C-III controlled drug
ANESTHETICS COMMENTS
Partially reversible with Yobine® (yohimbine)
Partially reversible with Yobine® (yohimbine)
Partially reversible with Yobine® (yohimbine)
Reversible with Antesedan® (atipamezole) or Yobine®
Can be irritating Apnea possible, esp. if given too quickly
Partially reversible with Yobine® (yohimbine)
FERRET REVERSAL AGENTS
1 Ketamine used alone in mammals is not usually adequate for deep anesthesia. 2 C-III controlled drug 3 C-IV controlled drug 4 C-II controlled drug 5 Survival procedures require the use of a precision vaporizer for isoflurane gas delivery.
ANALGESICS (PAIN RELIEVERS) FREQUENCY COMMENTS
GI side effects; low-grade teratogen; may
May cause respiratory depression
1 NSAID 2 Opioid 3 C-III controlled drug
SEDATIVES COMMENTS
Partially reversible with Yobine® (yohimbine)
Partially reversible with Yobine® (yohimbine)
Partially reversible with Yobine® (yohimbine)
Reversible with Antesedan® (atipamezole) or Yobine®
FERRET REVERSAL AGENTS
1 Ketamine used alone in mammals is not usually adequate for deep anesthesia. 2 C-III controlled drug 3 C-IV controlled drug
ANESTHETICS COMMENTS MAC = 2.05%
Partially reversible with Yobine® (yohimbine)
Partially reversible with Yobine® (yohimbine)
Reversible with Antesedan® (atipamezole) or Yobine®
Provides approx. 30% longer anesthesia and recovery than
Reversible with Antesedan® (atipamezole) or Yobine®
RABBIT REVERSAL AGENTS
1 Ketamine used alone in mammals is not usually adequate for deep anesthesia. 2 C-III controlled drug 3 C-IV controlled drug 4 C-II controlled drug 5 Survival procedures require the use of a precision vaporizer for isoflurane gas delivery.
ANALGESICS (PAIN RELIEVERS) FREQUENCY COMMENTS May cause respiratory depression;
1 NSAID 2 Opioid 3 C-III controlled drug 4 C-II controlled drug
SEDATIVES COMMENTS
Mild to moderate sedation; duration 4 hr Partially reversible
Mild to moderate sedation; duration 4 hr Partially reversible
with Yobine® (yohimbine); lower end of dose range preferred
Moderate to deep sedation; duration 30 to 180 min
Moderate to heavy sedation; duration 1 hr (IM) or 15 – 20 min
Partially reversible with Yobine® (yohimbine)
Moderate to deep sedation; duration < 2 hr
Moderate to profound sedation; duration 30 – 60 min
Reversible with Antesedan® (atipamezole) or Yobine®
RABBIT REVERSAL AGENTS
1 Ketamine used alone in mammals is not usually adequate for deep anesthesia. 2 C-III controlled drug 3 C-IV controlled drug
WOODCHUCKS ANESTHETICS, SEDATIVES and ANALGESICS (PAIN RELIEVERS) FREQUENCY COMMENTS May cause respiratory depression
1 Ketamine used alone in mammals is not usually adequate for deep anesthesia. 2 C-III controlled drug 3 Opioid 4 NSAID 5 Survival procedures require the use of a precision vaporizer for isoflurane gas delivery.
NONHUMAN PRIMATE ANESTHETICS FREQUENCY COMMENTS
Often vomit on induction; surgical anesthesia
Partially reversible with Yobine® (yohimbine)
Partially reversible with Yobine® (yohimbine)
Partially reversible with Yobine® (yohimbine)
Provides ≤ 45 min restraint/anesthesia
200 – 600 µg/kg Apnea common
Partially reversible with Yobine® (yohimbine)
NONHUMAN PRIMATE REVERSAL AGENTS
1 Ketamine used alone in mammals is not usually adequate for deep anesthesia. 2 C-III controlled drug 3 C-IV controlled drug 4 C-II controlled drug 5 Survival procedures require the use of a precision vaporizer for isoflurane gas delivery.
NONHUMAN PRIMATE ANALGESICS (PAIN RELIEVERS) FREQUENCY COMMENTS May cause respiratory depression; NONHUMAN PRIMATES SEDATIVES FREQUENCY COMMENTS
Provides ≤ 45 min restraint/anesthesia
NONHUMAN PRIMATE REVERSAL AGENTS
1 Ketamine used alone in mammals is not usually adequate for deep anesthesia. 2 C-III controlled drug 3 C-IV controlled drug
ANESTHETICS FREQUENCY COMMENTS IV - Slowly, to effect SWINE REVERSAL AGENTS
1 Ketamine used alone in mammals is not usually adequate for deep anesthesia. 2 C-IV controlled drug 3 C-II controlled drug 4 C-III controlled drug 5 Survival procedures require the use of a precision vaporizer for isoflurane gas delivery.
MISCELLANEOUS DRUGS – MALIGNANT HYPERTHERMIA TREATMENT FREQUENCY COMMENTS Give slowly; analgesic, antipyretic, ANALGESICS (PAIN RELIEVERS) FREQUENCY COMMENTS May cause respiratory depression
50 ug/hr patch
1 NSAID 2 Opioid 3 C-III controlled drug 4 C-II controlled drug
SEDATIVES FREQUENCY COMMENTS Max 15 mg total SWINE REVERSAL AGENTS AMPHIBIANS SEDATIVES and ANESTHETICS COMMENTS
For Larvae
Dissolve in ethanol or acetone before water.
Use product from chemical suppliers or fish anesthetic
preparations; do not use mammalian preparations
For Frogs and Salamanders Terrestrial species Remove excess once anesthetized
Induction and recovery can be prolonged; variable response
For Tadpoles & Newts
200 – 500 mg/l
0.02 - .0.05% solution to effect; buffer with NaHCO
Na2HPO4; adjust pH to 7.0 – 7.4; use well-oxygenated,
For Frogs, Salamanders
500 – 2000 mg/l
0.05 – 0.2% solution to effect; buffer with NaHCO
2HPO4; adjust pH to 7.0 – 7.4; use well-oxygenated,
For Toads
0.1 – 0.3% solution to effect; buffer with NaHCO
1 – 3 g/l bath
Na2HPO4; adjust pH to 7.0 – 7.4; use well-oxygenated,
1 Survival procedures require the use of a precision vaporizer for isoflurane gas delivery. 2 C-III controlled drug 3 Sample preparation protocol: Mix 2 grams of MS-222 with 34 to 50 ml of 0.5M Na2HPO4 (buffer) in 2 L of oxygenated water. Adjust pH to 7.0 – 7.4. Dilute as required with well-oxygenated, toxin-free water.
REPTILES ANESTHETICS, SEDATIVES and ANALGESICS FREQUENCY COMMENTS
Standard agent for reptiles but may hold their breath and resist effects of exposure to high concentrations of agent.
In anesthetic chamber +/- intubated after
induction. Recover in room air (not pure O
because reptiles are stimulated to breathe by
decreasing O2 levels, not increasing CO2
In snapping turtles, provides better sedation
inappropriate choice as sole agent for general anesthesia
1 Survival procedures require the use of a precision vaporizer for isoflurane gas delivery. 2 Induction 10 - 30 minutes after injection. Prolonged recovery (24 – 96 hours) 3 C-III controlled drug 4 C-IV controlled drug 5 Consider metabolic scaling in reptiles; larger animals often require much SMALLER doses to achieve same result. 6 Opioid 7 NSAID DCM FORMULARY REFERENCES
Allen, Dana G. (2005). Handbook of veterinary drugs, ed 3. Baltimore, MD: Lippincott Williams & Wilkins. Bennett, R. Avery (1998). Reptile anesthesia. Seminars in Avian and Exotic Pet Medicine 7(1):30-40.
http://dx.doi.org/10.1016/S1055-937X(98)80055-8
Carpenter, James W. (2005). Exotic animal formulary, ed 3. St. Louis, MO: Elsevier Saunders. Fish, Richard E., Marilyn J. Brown, Peggy J. Danneman, & Alicia Z. Karas, Eds. (2008). Anesthesia and analgesia in laboratory animals, ed 2. Burlington, MA: Academic Press.
Flecknell, Paul. (2009). Laboratory animal anesthesia, ed 3. Burlington, MA: Academic Press. Flecknell, Paul & Avril Waterman-Pearson, Eds. (2000). Pain management in animals. London: W.B.
Gaynor, James S. & William W. Muir, III. (2002). Handbook of veterinary pain management. St. Louis, MO:
Harcourt-Brown, Frances. (2002). Textbook of rabbit medicine. Oxford: Butterworth Heinemann. Hawk, C. Terrance, Steven L. Leary, & Timothy H. Morris. (2005). Formulary for laboratory animals, ed 3.
accessed at 4:08 PM (EST) on Thursday, July 25, 2013. Lewington, John H. (2007). Ferret husbandry, medicine and surgery, ed 2. Edinburgh: Saunders Elsevier. Longley, L. A. (2008). Anaesthesia of exotic pets. Edinburgh: Saunders Elsevier. Oglesbee, Barbara L. (2006). The 5-minute veterinary consult: Ferret and rabbit. Ames, IA: Blackwell. Papich, Mark G. (2002). Saunders handbook of veterinary drugs. Philadelphia, PA: Saunders. Plumb, Donald C. (2008). Plumb’s veterinary drug handbook, ed 6. Ames, IA: Blackwell.
human psychopharmacologyHum Psychopharmacol Clin Exp 2005; 20: 183–187. Published online 7 February 2005 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/hup.676A comparison of donepezil and galantamine in thetreatment of cognitive symptoms of Alzheimer’sdisease: a meta-analysisRobin D. J. Harry and Konstantine K. Zakzanis*University of Toronto at Scarborough, Toronto, Canad
W . U . S . H E A L T H C E N T R E UNIVERSITY OF DELHI, DELHI-110007 Purchase of Drugs/Medicines & Other items for the year 2011-2012 TENDER NOTICE Sealed tenders are invited from manufactures having G.M.P. certification as per WHO distributors/suppliers having turnover of Rs. Three crore or above per annum (not applicable to Laboratory Chemicals & Glasswares, Dress